{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:50:10Z","timestamp":1787759410923,"version":"build-2784847793"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T00:00:00Z","timestamp":1737676800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/j.ijid.2025.107803","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T16:20:40Z","timestamp":1737994840000},"page":"107803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)"],"prefix":"10.1016","volume":"153","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7022-6644","authenticated-orcid":false,"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo E.","family":"Mendes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Doyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marisa L.","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana","family":"Castanheira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2025.107803_bib0001","doi-asserted-by":"crossref","first-page":"dlac040","DOI":"10.1093\/jacamr\/dlac040","article-title":"Clinical challenges treating Stenotrophomonas maltophilia infections: an update","volume":"4","author":"Mojica","year":"2022","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.ijid.2025.107803_bib0002","doi-asserted-by":"crossref","first-page":"ofaa141","DOI":"10.1093\/ofid\/ofaa141","article-title":"The burden of bloodstream infections due to Stenotrophomonas maltophilia in the United States: a large, retrospective database study","volume":"7","author":"Cai","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.107803_bib0003","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s00284-023-03524-5","article-title":"Stenotrophomonas maltophilia: an urgent threat with increasing antibiotic resistance","volume":"81","author":"Liu","year":"2023","journal-title":"Curr Microbiol"},{"key":"10.1016\/j.ijid.2025.107803_bib0004","doi-asserted-by":"crossref","first-page":"ciae403","DOI":"10.1093\/cid\/ciae403","article-title":"Infectious diseases society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections","volume":"79","author":"Tamma","year":"2024","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107803_bib0005","unstructured":"European Medicines Agency. New antibiotic to fight infections caused by multidrug-resistant bacteria. Netherlands. 2024. https:\/\/www.ema.europa.eu\/en\/news\/new-antibiotic-fight-infections-caused-multidrug-resistant-bacteria. accessed 10 January 2025."},{"key":"10.1016\/j.ijid.2025.107803_bib0006","doi-asserted-by":"crossref","first-page":"ofad046","DOI":"10.1093\/ofid\/ofad046","article-title":"Changing epidemiology of carbapenemases among carbapenem-resistant enterobacterales from United States hospitals and the activity of Aztreonam-Avibactam against contemporary enterobacterales (2019-2021)","volume":"10","author":"Sader","year":"2023","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ijid.2025.107803_bib0007","series-title":"Performance standards for antimicrobial susceptibility testing: 34th informational supplement","year":"2024"},{"key":"10.1016\/j.ijid.2025.107803_bib0008","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1093\/jac\/dkz497","article-title":"Pharmacokinetics and safety of aztreonam\/avibactam for the treatment of complicated intra-abdominal infections in hospitalized adults: results from the REJUVENATE study","volume":"75","author":"Cornely","year":"2020","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2025.107803_bib0009","unstructured":"EUCAST. Breakpoint tables for interpretation of MIC's and zone diameters version 14.0. European Committee on Antimicrobial Susceptibility Testing 2024. Available at: https:\/\/www.eucast.org\/fileadmin\/src\/media\/PDFs\/EUCAST_files\/Breakpoint_tables\/v_14.0_Breakpoint_Tables.pdf. accessed 13 February 2025."},{"key":"10.1016\/j.ijid.2025.107803_bib0010","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/QCO.0000000000000975","article-title":"Treatment approaches for severe Stenotrophomonas maltophilia infections","volume":"36","author":"Mojica","year":"2023","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.ijid.2025.107803_bib0011","doi-asserted-by":"crossref","first-page":"910","DOI":"10.3390\/antibiotics12050910","article-title":"Stenotrophomonas maltophilia Infections: a systematic review and meta-analysis of comparative efficacy of available treatments, with critical assessment of novel therapeutic options","volume":"12","author":"Maraolo","year":"2023","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.ijid.2025.107803_bib0012","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1093\/jac\/dkaa197","article-title":"Determining the optimal dosing of a novel combination regimen of ceftazidime\/avibactam with aztreonam against NDM-1-producing Enterobacteriaceae using a hollow-fibre infection model","volume":"75","author":"Lodise","year":"2020","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122500027X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197122500027X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,15]],"date-time":"2025-03-15T11:21:26Z","timestamp":1742037686000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197122500027X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4]]},"references-count":12,"alternative-id":["S120197122500027X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107803","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antimicrobial susceptibility of clinical isolates of Stenotrophomonas maltophilia from Europe, Asia, and Latin America (2018-2023)","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2025.107803","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"107803"}}